EDWARD G. TORRANCE, M.D.; TRUMAN G. SCHNABEL, M.D., F.A.C.P.
TORRANCE EG, SCHNABEL TG. Potassium Sulphocyanate: A Note on Its Use for the Painful Crises in Sickle Cell Anemia. Ann Intern Med. 1932;6:782-788. doi: 10.7326/0003-4819-6-6-782
Download citation file:
Published: Ann Intern Med. 1932;6(6):782-788.
Sickle cell anemia is a disease of unknown etiology, its prognosis is uncertain and its treatment is entirely symptomatic. In its active stage it is noteworthy for its spontaneous remissions and relapses. Most observers have found that treatments thus far suggested do not materially alter the course of the disease. No therapeutic procedure seems to influence the degree of sickling in vivo. Blood transfusions bring about remissions with uncertain regularity, and are of temporary value when so induced. They do on occasions tide a severely anemic patient over a critical period.
Liver diet has been tried by Sydenstricker1 and others
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only